Korean J Infect Dis.  2000 Feb;32(1):78-81.

Fatal Cytomegalovirus Pneumonia in a Immunocompetent Patient

Affiliations
  • 1Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Abstract

Serious cytomegalovirus (CMV) infection occurs frequently in immunocompromised patients and is a common cause of death. Although primary infection in immunocompetent hosts is normally subclinical, mononucleosis-like syndrome that is characterized by malaise, protracted fever, mild liver function abnormalities, and lymphocytosis with atypical lymphocytes occurs in -10% of patients. Rarely fulminant infection may develop. In both the United States and the United Kingdom, ganciclovir and foscarnet are recommended for the treatment of serious CMV infections in immunocompromised patients. In contrast, there are no recommendations for treatment of severe CMV disease in immunocompetent patients. We describe a case of 45-year-old woman with CMV pneumonia with a fatal outcome for whom there was no evidence of prior immunodeficiency.

Keyword

Cytomegalovirus pneumonia; Immunocompetent; Ganciclovir

MeSH Terms

Cause of Death
Cytomegalovirus*
Fatal Outcome
Female
Fever
Foscarnet
Ganciclovir
Great Britain
Humans
Immunocompromised Host
Liver
Lymphocytes
Lymphocytosis
Middle Aged
Pneumonia*
United States
Foscarnet
Ganciclovir
Full Text Links
  • KJID
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr